The president and the pheochromocytomaFranz H Messerli
St Luke s Roosevelt Hospital Center, New York, New York, USA
Am J Cardiol 99:1325-9. 2007
..In conclusion, most likely, the pheochromocytoma was the underlying cause of this erratic blood pressure pattern and may have worsened the course of the president's ischemic cardiomyopathy...
beta-Blockers in hypertension: is carvedilol different?Franz H Messerli
Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
Am J Cardiol 93:7B-12B. 2004
....
b-Blockers and hypertension: A therapeutic reappraisalFranz H Messerli
New York, NY 10019, USA
Postgrad Med 118:26-33. 2005
..Here, the authors consider the extended debate on this topic and discuss the mechanisms of action for traditional and newer b-blockers and their role in hypertension management...
Evolution of calcium antagonists: past, present, and futureFranz H Messerli
Section on Hypertensive Diseases, Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
Clin Cardiol 26:II12-6. 2003
..Newer calcium antagonists demonstrate antihypertensive efficacy similar to that of their predecessors but appear to have a reduced propensity to cause edema...
If only cardiologists did properly measure blood pressure. Blood pressure recordings in daily practice and clinical trialsFranz H Messerli
Ochsner Clinic Foundation, New Orleans, Louisiana, USA
J Am Coll Cardiol 40:2201-3. 2002
..Whether measured in office or clinical trials, BP is an important clinical tool that should be treasured by practitioners and clinical investigators alike...
The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?Franz H Messerli
Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, New York 10019, USA
J Am Coll Cardiol 54:1827-34. 2009
..However, these concerns should not deter physicians from pursuing a more aggressive control of hypertension, because currently blood pressure is brought to recommended target levels in only approximately one-third of patients...
Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study)Franz H Messerli
Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA
Am J Cardiol 90:1133-4. 2002
Vasodilatory edema: a common side effect of antihypertensive therapyFranz H Messerli
Department of Internal Medicine, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA
Curr Cardiol Rep 4:479-82. 2002
..Thus, low-dose combination therapy (of a dihydropyridine calcium antagonist with either an ACE inhibitor or an ARB) may be preferred over high-dose monotherapy...
Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?Franz H Messerli
Division of Cardiology, St Luke s Roosevelt Hospital Center, 1000 10th Avenue, New York, NY 10019, USA
Cleve Clin J Med 76:693-6. 2009
..No. Dual renin-angiotensin system blockade has never been shown to reduce the rates of morbidity or death from any cause...
ALLHAT, or the soft science of the secondary end pointFranz H Messerli
Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
Ann Intern Med 139:777-80. 2003
....
Do thiazide diuretics confer specific protection against strokes?Franz H Messerli
Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA
Arch Intern Med 163:2557-60. 2003
....
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trialFranz H Messerli
St Luke s Roosevelt Hospital Center, New York, NY 10019, USA
J Clin Hypertens (Greenwich) 8:571-81; quiz 582-3. 2006
..Concomitant administration of amlodipine and atorvastatin is an effective and well tolerated treatment for coexisting hypertension and dyslipidemia...
Body weight changes with beta-blocker use: results from GEMINIFranz H Messerli
St Luke s Roosevelt Hospital Center, New York City, NY 10019, USA
Am J Med 120:610-5. 2007
....
Essential hypertensionFranz H Messerli
Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, New York, NY 10019, USA
Lancet 370:591-603. 2007
..Despite the availability of effective and safe antihypertensive drugs, hypertension and its concomitant risk factors remain uncontrolled in most patients...
Therapeutic controversies in hypertensionFranz H Messerli
St Lukes Roosevelt Hospital Center, New York, NY 10019, USA
Semin Nephrol 25:227-35. 2005
..The long-term safety of antihypertensive therapy is documented poorly because most trials only last 4 to 6 years. Despite these drawbacks and concerns, the benefits of antihypertensive therapy clearly outweigh its potential risk...
When premature is not premature--the ASCOT studyFranz H Messerli
Department of Cardiology, St Luke's-Roosevelt Hospital Center, Columbia University, 1000, Tenth Avenue, Suite 3B-30, New York 10019, NY, USA
Eur Heart J 26:1822-3. 2005
Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysisFranz H Messerli
Division of Cardiology, St Luke s Roosevelt Hospital, New York, New York, USA
Am J Cardiol 101:319-25. 2008
..51, p=0.22). In conclusion, statin therapy effectively decreases CV morbidity and mortality to the same extent in hypertensive and nonhypertensive patients...
Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertensionFranz H Messerli
Division of Cardiology, St Luke's-Roosevelt Hospital, Columbia University College of Physicians and Surgeons, 1000 10th Ave, Suite 3B-30, New York, NY 10019, USA
Circulation 117:2706-15; discussion 2715. 2008
Safety of calcium antagonists: more ACTIONFranz H Messerli
St. Lukes-Roosevelt Hospital Corporation, New York City, New York, USA
Am J Med 118:1418-20. 2005
Calcium antagonists in hypertension: from hemodynamics to outcomesFranz H Messerli
Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 15:94S-97S. 2002
..These micro- and macrovascular features make lercanidipine an attractive new member in the arsenal of the powerful dihydropyridine calcium antagonists...
Blood pressure control in stroke patients: what should the consulting neurologist advise?Franz H Messerli
Department of Internal Medicine, Ochsner Clinic Foundation, New Orleans, LA 70121, USA
Neurology 59:23-5. 2002
High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?E Grossman
Ochsner Clinic, 1514 Jefferson Hwy, New Orleans, LA 70121
Arch Intern Med 160:2447-52. 2000
..To analyze the available data to assess the benefits of antihypertensive therapy in hypertensive patients with diabetes mellitus...
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic reviewF H Messerli
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA 70121, USA
JAMA 279:1903-7. 1998
..To assess antihypertensive efficacy of beta-blockers and their effects on cardiovascular morbidity and mortality and all-cause morbidity compared with diuretics in elderly patients with hypertension...
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?Franz H Messerli
Division of Cardiology, St Luke s Roosevelt Hospital, New York, New York 10019, USA
Ann Intern Med 144:884-93. 2006
..Because coronary perfusion occurs mainly during diastole, patients with coronary artery disease (CAD) could be at increased risk for coronary events if diastolic pressure falls below critical levels...
Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patientsF H Messerli
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana, USA
J Hypertens 19:977-82. 2001
..To analyse effects of a heart rate-lowering calcium antagonist in hypertensive post-myocardial infarction patients...
Doxazosin and congestive heart failureF H Messerli
Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
J Am Coll Cardiol 38:1295-6. 2001
..Therefore, until ironclad safety data are provided, doxazosin, and probably all alpha-blockers, should no longer be used as first-line antihypertensive therapy...
Carcinogenicity of antihypertensive therapyEhud Grossman
Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA
Curr Hypertens Rep 4:195-201. 2002
..With regard to other antihypertensive drug classes, we suggest continuing the management of hypertension according to current treatment guidelines with little fear of any substantial cancer risk...
Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based settingFranz H Messerli
Division of Research, Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 15:550-6. 2002
..This large practice-based clinical trial assessed the efficacy and tolerability of fixed-dose combination therapy with amlodipine/benazepril, compared with amlodipine monotherapy, in patients with mild-to-moderate hypertension...
Antihypertensive therapy in diabetic hypertensive patientsF H Messerli
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 14:12S-16S. 2001
..Combination of more than one drug is frequently required to control BP and may be more beneficial than monotherapy...
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudySripal Bangalore
Division of Cardiovascular Medicine, St Luke s Roosevelt Hospital Center, New York, NY 10025, USA
Am Heart J 156:241-7. 2008
..The purpose of the study was to compare a beta-blocker-based strategy with a heart rate-lowering calcium antagonists-based strategy in patients with prior MI...
Combination therapy and target organ protection in hypertension and diabetes mellitusF H Messerli
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 10:198S-201S. 1997
..The combination of a heart rate lowering calcium antagonist, particularly verapamil, with an ACE inhibitor offers some potential to either prevent or reverse target organ disease associated with hypertension and diabetes...
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINIV Fonseca
Tulane University, New Orleans, LA 70112, USA
Diabet Med 24:759-63. 2007
..To determine whether the beneficial effects of carvedilol on insulin resistance (IR) are affected by the concomitant use of insulin sensitizers [thiazolidinediones (TZDs) and metformin]...
Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonistsF H Messerli
Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana, USA
Am J Hypertens 12:86S-90S. 1999
..However, their use together in left ventricular hypertrophy and in patients with coronary heart disease, although promising, must be proved through carefully designed, prospective, randomized trials...
Obesity paradox in patients with hypertension and coronary artery diseaseSeth Uretsky
Division of Cardiology, St Luke s Roosevelt Hospital, New York, NY, USA
Am J Med 120:863-70. 2007
..However, whether this phenomenon exists in patients with hypertension and coronary artery disease is not known...
Beta-blockers and diuretics: to use or not to useF H Messerli
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 12:157S-163S. 1999
..Sweeping recommendations for the use of beta-blockers and diuretics as preferred therapeutic strategies are inappropriate and a more sophisticated drug therapy regimen is often needed...
Hemodynamic effects of celiprolol in essential hypertensionE D Frohlich
Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121
Am J Cardiol 68:509-14. 1991
..These effects may be explained by celiprolol's cardiac beta-1 receptor inhibitory and peripheral beta-2 receptor agonistic effects...
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitusSripal Bangalore
Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York, NY, USA
Am J Cardiol 100:1254-62. 2007
..This risk was greater in patients with higher baseline body mass indexes and higher baseline fasting glucose levels and in studies in which beta blockers were less efficacious antihypertensive agents compared with other treatments...
Calcium antagonists and beta-blockers: impact on cardiovascular and cerebrovascular eventsFranz H Messerli
St Luke s Roosevelt Hospital Center, New York, New York 10019, USA
Clin Cornerstone 6:18-27. 2004
..This article reviews the data on risk reduction involving the beta-blockers and calcium antagonists, as well as other antihypertensive classes that have been shown to reduce the risk of cerebrovascular and cardiovascular disease...
The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end pointFranz H Messerli
Division of Cardiology, St Luke s Roosevelt Hospital Center, Columbia University College of Medicine and Physicians, New York, NY 10019, USA
J Am Coll Cardiol 53:468-70. 2009
..Unless data emerge to the contrary, dual RAS blockade should no longer be used in clinical practice...
Feasibility of treating prehypertension with an angiotensin-receptor blockerStevo Julius
University of Michigan, Department of Internal Medicine, Division of Cardiovascular Medicine, Ann Arbor, MI 48106, USA
N Engl J Med 354:1685-97. 2006
..Prehypertension is considered a precursor of stage 1 hypertension and a predictor of excessive cardiovascular risk. We investigated whether pharmacologic treatment of prehypertension prevents or postpones stage 1 hypertension...
Fixed-dose combinations improve medication compliance: a meta-analysisSripal Bangalore
Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital and Columbia University, New York, NY 10025, USA
Am J Med 120:713-9. 2007
..However the data on comparison of fixed-dose combination with free-drug regimen to improve patient's medication compliance is limited...
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysisSripal Bangalore
Division of Cardiology, Department of Medicine, Columbia University College of Physicians and Surgeons, St Luke s Roosevelt Hospital Center, 1000 Tenth Avenue, Suite 3B 30, New York, NY 10025, USA
Eur Heart J 30:1395-401. 2009
....
Hypertension in the elderly: a compelling contraindication for beta-blockers?S Bangalore
Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital and Columbia University, New York, NY 10019, USA
J Hum Hypertens 21:259-60. 2007
Cardioprotection with beta-blockers: myths, facts and Pascal's wagerF H Messerli
Division of Cardiology, St Luke s and Roosevelt Hospitals, Columbia University College of Physicians and Surgeons, New York, NY 10019, USA
J Intern Med 266:232-41. 2009
..Thus, recent evidence argues against universal cardioprotective properties of beta-blockers but attest to their usefulness for specific cardiovascular indications...
A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockersS Bangalore
Division of Cardiology, Department of Medicine, St Luke's-Roosevelt Hospital and Columbia University, New York, NY 10025, USA
Int J Clin Pract 60:1281-6. 2006
..Moreover, the incidence of stroke is significantly related to baseline BP, which may be an important factor to consider when deciding on treatment strategies in high-risk patients with CAD...
Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effectG E Garavaglia
Department of Internal Medicine, Ochsner Clinic, New Orleans, LA 70121
Am J Hypertens 1:214S-216S. 1988
..These findings suggest that systemic and renal hemodynamic effects may be drug specific and not uniform for all ACE inhibitors...
Compliance and fixed-dose combination therapySripal Bangalore
Hypertension Program, Division of Cardiology, Columbia University College of Physicians and Surgeons, St Luke s Roosevelt Hospital Center, 1000 Tenth Avenue, Suite 3B 30, New York, NY 10025, USA
Curr Hypertens Rep 9:184-9. 2007
..Fixed-dose combinations should be used routinely for the management of hypertension and should also be considered when initiating therapy for patients with newly diagnosed hypertension...
Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertensionSripal Bangalore
Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, New York 10019, USA
J Am Coll Cardiol 52:1482-9. 2008
..The purpose of this study was to evaluate the role of heart rate reduction with beta-blockers on the risk of cardiovascular events in patients with hypertension...
Cardiac effects of combination therapyF H Messerli
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 10:146S-152S. 1997
..Thus, combination therapy should primarily be used for lowering arterial pressure and only secondarily to possibly improve concomitant pathophysiologic conditions associated with hypertensive heart disease...
Desperate diseases, desperate measures: tackling malignant hypertension in the 1950sH O Ventura
Department of Cardiology, and the Section of Hypertension, Department of Medicine, Ochsner Medical Institutions, New Orleans, LA 70121, USA
Am Heart J 142:197-203. 2001
..As we enter the new millennium, it is critical to examine the efforts that have led to our ability to treat this once incurable disease...
What, if anything, is controversial about calcium antagonists?F H Messerli
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 9:177S-181S. 1996
....
Cardiovascular adaptation to cyclosporine-induced hypertensionH O Ventura
Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, LA 70112
J Hum Hypertens 8:233-7. 1994
..The cardiac adaptation to cyclosporine-induced hypertension has more severe concentric left ventricular hypertrophy and impaired left ventricular systolic performance.(ABSTRACT TRUNCATED AT 250 WORDS)..
Efficacy and safety of angiotensin II receptor blockers in elderly patients with mild to moderate hypertensionC E Okereke
Department of Internal Medicine, Section on Hypertensive Diseases, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, LA, USA
Am J Geriatr Cardiol 10:42-9. 2001
..Combination therapy with angiotensin receptor blockers and hydrochlorothiazide was additive, without any significant effect on the safety profile...
Hypertension and sudden cardiac deathF H Messerli
Department of Internal Medicine, Ochsner Clinic and Alton Ochsner Medical Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 12:181S-188S. 1999
....
Beta-blockers: no longer an option for uncomplicated hypertensionSripal Bangalore
Hypertension Program, Division of Cardiology, St Luke s Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, NY 10019, USA
Curr Cardiol Rep 9:441-6. 2007
..This article reviews the data available from clinical trials and argues that beta-blockers are less efficacious than other currently available antihypertensive agents for patients with uncomplicated hypertension...
Beta-blockers for primary prevention in hypertension: era bygone?Gurusher S Panjrath
Department of Cardiology, St Lukes Roosevelt Hospital Center, Division of Cardiology, Columbia University, NY 10019, USA
Prog Cardiovasc Dis 49:76-87. 2006
..Newer beta-blockers have additional properties which may be beneficial. Although, whether these additional benefits will help in primary prevention is not clear...
beta-Blockers in hypertension-the emperor has no clothes: an open letter to present and prospective drafters of new guidelines for the treatment of hypertensionFranz H Messerli
Ochsner Clinic Foundation, New Orleans, Louisiana 70121, USA
Am J Hypertens 16:870-3. 2003
....
Eisenhower's billion-dollar heart attack--50 years laterFranz H Messerli
St. Luke's-Roosevelt Hospital Center, New York, USA
N Engl J Med 353:1205-7. 2005
A novel pathway for the management of hypertension for hospitalized patientsEyal Herzog
Division of Cardiology, St Luke s Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York City, New York 10025, USA
Crit Pathw Cardiol 6:150-60. 2007
..Finally, the pathway provides a step by step recommendation for the management of in hospital HTN and of hypertensive emergencies...
Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysisSripal Bangalore
Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York, New York 10019, USA
J Am Coll Cardiol 52:1062-72. 2008
..This study sought to evaluate the efficacy of beta-blockers (BBs) for primary prevention of heart failure (HF) in patients with hypertension...
Cardiovascular protection using beta-blockers: a critical review of the evidenceSripal Bangalore
St Luke s Roosevelt Hospital and Columbia University, New York, New York 10019, USA
J Am Coll Cardiol 50:563-72. 2007
..However, beta-blockers remain very efficacious agents for the treatment of heart failure, certain types of arrhythmia, hypertropic obstructive cardiomyopathy, and in patients with prior myocardial infarction...
When guidelines need guidanceFranz H Messerli
Division of Cardiology, St. Luke's Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, NY, USA
Am J Med 121:742-3. 2008
Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysisSripal Bangalore
Division of Cardiology, Brigham and Women s Hospital, Boston, MA, USA
Lancet 372:1962-76. 2008
..We aimed to critically review the evidence to assess the use of perioperative beta blockers in patients having non-cardiac surgery...
The association of the Friesinger score and pulse pressure in an urban South Asian patient population: pulse pressure, an independent predictor of coronary artery diseaseFahad Javed
St Luke s Roosevelt Hospital Center, University Hospital of College of Physicians and Surgeons of Columbia University, New York, NY, USA
J Am Soc Hypertens 4:142-7. 2010
..7 vs. 20.3; P = .1139). Our study demonstrates that pulse pressure, a well-established marker of vascular health, is a significant independent predictor of the severity of CAD as assessed by coronary angiography in South Asians...
How useful are beta-blockers in cardiovascular disease?Sripal Bangalore
Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital, Columbia University, New York, New York 10019, USA
Anadolu Kardiyol Derg 6:358-63. 2006
..However, this is applicable for hypertension and beta-blockers continue to be efficacious for other indications...
Left ventricular geometry and survival in patients with normal left ventricular ejection fractionRichard V Milani
Department of Cardiology Ochsner Clinic Foundation, New Orleans, Louisiana, USA
Am J Cardiol 97:959-63. 2006
..Normalization of CR is associated with better survival, whereas transition to LV hypertrophy increases mortality...
Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysisSripal Bangalore
Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital and Columbia University College of Physicians and Surgeons, New York, NY 10019, USA
Am J Med 122:356-65. 2009
..Short-acting CCBs have an unfavorable hemodynamic profile. The role of long-acting CCBs in patients with coronary artery disease is unknown...
Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fractionCarl J Lavie
Department of Cardiology, Ochsner Medical Center, New Orleans, LA, USA
Am J Cardiol 100:1460-4. 2007
....
Left ventricular geometry and mortality in patients >70 years of age with normal ejection fractionCarl J Lavie
Ochsner Medical Center, New Orleans, Louisiana, USA
Am J Cardiol 98:1396-9. 2006
....
Effects of losartan in hypertension without vascular diseaseFranz H Messerli
Ann Intern Med 140:W29. 2004
Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trialsAlbert Fournier
, Amiens Cedex I, France
J Am Coll Cardiol 43:1343-7. 2004
..Stroke is the most devastating consequence of hypertensive cardiovascular disease, and our hypothesis of cerebroprotection by AT2 receptor activation should be tested by a head-to-head comparison of an ARB with an ACE inhibitor...
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril studyGeorge L Bakris
Rush Medical University, 1700 W Van Buren St, Suite 470, Chicago, IL
Hypertension 44:637-42. 2004
..Thus, a verapamil SR-based antihypertensive treatment strategy is an alternative to a beta-blocker-based strategy in adults with CAD and diabetes...
Are calcium antagonists beneficial in diabetic patients with hypertension?Ehud Grossman
Internal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel Hashomer, Israel
Am J Med 116:44-9. 2004
..We analyzed the available data to assess the effects of calcium antagonists in hypertensive patients with diabetes mellitus...
Perioperative beta blockadeSripal Bangalore
Lancet 372:1147-8; author reply 1148. 2008
Angiotensin-converting enzyme inhibitors and angioedema: estimating the riskMichael A Weber
Hypertension 51:1465-7. 2008
Reduction of stroke risk factorsJohn B Kostis
J Clin Hypertens (Greenwich) 9:49-56. 2007
..Also participating were Philip B. Gorelick, MD, MPH, Director, Center for Stroke Research, University of Illinois College of Medicine, Chicago, IL, and Franz H. Messerli, MD, St Luke's-Roosevelt Hospital Center, New York, NY...
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trialCarl J Pepine
Division of Cardiovascular Medicine, Department of Medicine, University of Florida College of Medicine, Gainesville 32610, USA
JAMA 290:2805-16. 2003
..CONCLUSION: The verapamil-trandolapril-based strategy was as clinically effective as the atenolol-hydrochlorothiazide-based strategy in hypertensive CAD patients...
ALLHAT--all hit or all miss? Key questions still remainFranz H Messerli
Am J Cardiol 92:280-1. 2003
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertensionArnfried U Klingbeil
Department of Medicine IV, , Nuremberg, Germany
Am J Med 115:41-6. 2003
..CONCLUSIONS: Antihypertensive drug classes have different effects on left ventricular mass reduction. Whether a greater reduction of left ventricular mass results in better clinical outcomes remains to be determined...
Long-term cardiovascular consequences of diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitorsFranz H Messerli
JAMA 289:2067-8; author reply 2069-70. 2003
The LIFE study: the straw that should break the camel's backFranz H Messerli
Eur Heart J 24:487-9. 2003
Losartan vs atenolol in prevention of stroke and cardiovascular diseaseFranz H Messerli
JAMA 289:700-1; author reply 701. 2003
Pedal edema--not all dihydropyridine calcium antagonists are created equalFranz H Messerli
Am J Hypertens 15:1019-20. 2002
Why beta-blockers are not cardioprotective in elderly patients with hypertensionEhud Grossman
Internal Medicine D, The Chaim Sheba Medical Center, Tel Hashomer, 52621, Israel
Curr Cardiol Rep 4:468-73. 2002
..Decreased beta-adrenergic responsiveness with age and comorbid conditions makes beta-blockers unattractive. Thus, they should not be considered appropriate for first-line therapy of uncomplicated hypertension in the geriatric population...
Beta-blockers in the treatment of hypertension: new data, new directionsMichael A Weber
State University of New York, Downstate Medical College, 450 Clarkson Avenue, Brooklyn, NY 11023, USA
J Clin Hypertens (Greenwich) 10:234-8. 2008
Calcium antagonistsEhud Grossman
Internal Medicine D and Hyperstension Unit, The Chaim Sheba Medical Center, Tel-Hashomer, Israel
Prog Cardiovasc Dis 47:34-57. 2004
..Thus, calcium antagonists may be safely used in the management of hypertension and angina pectoris...
Effect of ramipril on the incidence of diabetesSripal Bangalore
N Engl J Med 356:522; author reply 523-4. 2007
Treatment of elderly hypertensive patients with a delayed-release verapamil formulation in a community-based trialMichael A Weber
State University of New York Downstate College of Medicine, Brooklyn, NY 11203, USA
Am J Geriatr Cardiol 13:131-6. 2004
..CODAS verapamil was found to be efficacious and well tolerated among elderly hypertensive patients in this community trial...
Amlodipine/atorvastatin for preventing heart diseaseFranz H Messerli
Am Fam Physician 75:311; author reply 311-2. 2007
Do we need yet another blocker of the renin-angiotensin system?Franz H Messerli
J Am Coll Cardiol 49:1164-5. 2007
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST])Rhonda Cooper-DeHoff
University of Florida College of Medicine, Gainesville, Florida, USA
Am J Cardiol 98:890-4. 2006
....
Amlodipine better than lisinopril? How one randomized clinical trial ended fallacies from observational studiesFranz H Messerli
Hypertension 48:359-61. 2006
Long-term safety of antihypertensive therapyEhud Grossman
Internal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel Hashomer, Israel
Prog Cardiovasc Dis 49:16-25. 2006
..Despite the concern that has been raised regarding the long-term safety of some antihypertensive agents, it is clear that lowering BP is safe and beneficial...
Blood pressure control and sildenafil--carrot stick or sword of Damocles?Siu Sun Yao
Am J Cardiol 100:552-3. 2007
Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trialsJi Guang Wang
Studies Coordinating Centre, Hypertension and Cardiovascular Rehabilitation Unit, Department of Cardiovascular Diseases, University of Leuven, Belgium
Stroke 37:1933-40. 2006
..We reviewed the randomized controlled trials that evaluated the effects of an antihypertensive drug versus placebo or another antihypertensive agent of a different class on carotid intima-media thickness...
The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotectionLaurent Magy
Division of Neurology, CHU Limoges, France
Curr Pharm Des 11:3275-91. 2005
..The perspective of a renewal of therapeutical strategies to optimise the prevention of target organ damage and perhaps even some of the diseases of ageing, such as loss of cognitive function is emphasised...
Masked hypertension and white-coat hypertension: therapeutic navigation between scylla and charybdisFranz H Messerli
J Am Coll Cardiol 46:516-7. 2005
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI TrialJackson T Wright
Department of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA
J Clin Hypertens (Greenwich) 9:842-9. 2007
..The use of carvedilol compared with metoprolol did not effect glycemic control...
Characteristics of contemporary patients with hypertension and coronary artery diseaseRhonda M Cooper-Dehoff
Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida 32610 0277, USA
Clin Cardiol 27:571-6. 2004
..This is particularly true for black and Hispanic patients who have been underrepresented in randomized CAD trials...
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trialGeorge L Bakris
Department of Preventive Medicine, Rush University Medical Center, Chicago, Ill, USA
JAMA 292:2227-36. 2004
..The effects of the 2 beta-blockers on clinical outcomes need to be compared in long-term clinical trials...
Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVESTAntonio Coca
Hospital Clinic IDIBAPS, University of Barcelona, Barcelona, Spain
Stroke 39:343-8. 2008
..Accordingly, factors predicting stroke risk in hypertensive, clinically stable coronary artery disease patients were determined with data from the INternational VErapamil SR-trandolapril STudy (INVEST)...